Your browser doesn't support javascript.
loading
Association of early suspected acute exacerbations of idiopathic pulmonary fibrosis with subsequent clinical outcomes and healthcare resource utilization.
Yu, Yanni F; Macaulay, Dendy S; Reichmann, William M; Wu, Eric Q; Nathan, Steven D.
Afiliação
  • Yu YF; Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT 06877, USA. Electronic address: Yanni.Yu@boehringer-ingelheim.com.
  • Macaulay DS; Analysis Group, Inc., 10 Rockefeller Plaza, 15th Floor, New York, NY 10020, USA. Electronic address: Dendy.Macaulay@analysisgroup.com.
  • Reichmann WM; Analysis Group, Inc., 111 Huntington Avenue, 10th Floor, Boston, MA 02199, USA. Electronic address: Bill.Reichmann@gmail.com.
  • Wu EQ; Analysis Group, Inc., 111 Huntington Avenue, 10th Floor, Boston, MA 02199, USA. Electronic address: Eric.Wu@analysisgroup.com.
  • Nathan SD; Advanced Lung Disease and Transplant Program, Department of Medicine, Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, VA 22042, USA. Electronic address: Steven.Nathan@inova.org.
Respir Med ; 109(12): 1582-8, 2015 Dec.
Article em En | MEDLINE | ID: mdl-26607877
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) may be complicated by episodes of acute exacerbation. This study quantified the association between occurrence of suspected acute exacerbations of IPF (AEx-IPF) in the 6 months post-IPF diagnosis with clinical outcomes and IPF-related healthcare resource utilization (HRU). METHODS: U.S. pulmonologists participated in a retrospective chart review of IPF patients. Patient eligibility criteria included: 1) ≥40 years of age and a confirmed date of first IPF diagnosis with HRCT and/or lung biopsy between January 2011-June 2013; 2) 2 separate FVC results recorded around first diagnosis and 6 months post-diagnosis. Patients with a suspected AEx-IPF within 6 months post-diagnosis were categorized as "early AEx-IPF." Subsequent clinical outcomes and IPF-related HRU were assessed from 6 months post-diagnosis until the latest physician contact date. RESULTS: The sample included 490 IPF patients from 168 pulmonologists; 72 (15%) patients had a suspected early AEx-IPF. At IPF diagnosis, the mean (SD) age was 61 (11) years, 68% were male, and the mean FVC percent predicted was 60% (26%). Compared to patients without a suspected early AEx-IPF, patients with an early AEx-IPF had higher mortality risk (HR = 2.87, p < 0.001) and higher rates of subsequent suspected AEx-IPF (IRR = 3.87, p < 0.001), outpatient visits (IRR = 1.46, p < 0.001), ER visits (IRR = 4.39, p < 0.001), hospitalizations (IRR = 7.96, p < 0.001), and ICU stays (IRR = 9.74, p < 0.001). CONCLUSIONS: Using a large sample of IPF patients from varied practice settings, we found a strong relationship between suspected early AEx-IPF and worse subsequent clinical outcomes and increased IPF-related HRU. This relationship was particularly pronounced for acute resource use.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar Idiopática Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Aspecto: Implementation_research Limite: Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Respir Med Ano de publicação: 2015 Tipo de documento: Article País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar Idiopática Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Aspecto: Implementation_research Limite: Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Respir Med Ano de publicação: 2015 Tipo de documento: Article País de publicação: Reino Unido